Questions about
Play4Health

Play4Health is a behavioral field execution platform that turns daily medication routines into verified adherence proof and medical device returns — captured where care actually happens. No app to download, no sensors, no new infrastructure required.

We verify dose confirmations (photo of patient with device), treatment persistence over 90-day windows, device returns at pharmacy level (inhalers, insulin pens, auto-injectors), and caregiver engagement. Each action is verified via timestamped photo with duplicate and timeframe controls.

No. Play4Health is a compliance and engagement platform — not a clinical decision support tool and not a medical device. It does not provide treatment recommendations or diagnostic outputs. All clinical decisions remain with the patient's healthcare provider. The platform generates verified behavioral data for PSP, ESG, and EPR purposes.

No app download. Patients interact via a simple web link — no installation, no account creation friction. No sensors or IoT hardware required. The platform runs through smartphones patients and caregivers already have. This is a core design principle: zero new infrastructure.

The HAI is Play4Health's proprietary behavioral measurement standard. It combines five weighted dimensions — dose confirmation frequency (30%), 90-day persistence (25%), technique correctness (20%), caregiver engagement (15%), and device return rate (10%) — into a single score. It distinguishes between patients who are compliant under programme scaffolding and those who have genuinely internalized their treatment routine. Learn more about the HAI →

Primarily pharmaceutical and biotech companies running patient support programmes (PSPs), and organisations responsible for medical device stewardship or EPR compliance. Also NGOs, foundations, and public health programmes needing verified adherence data for donor reporting, health ministry engagement, or impact measurement.

Any condition requiring a prescribed device or a regular medication routine — asthma (inhalers), diabetes (pens, pumps), oncology (auto-injectors), and other chronic conditions. The platform is condition-agnostic: it verifies the behavioral action, not the clinical content.

Our core proof is from Southeast Asia (22,000+ verified actions). We're headquartered in Nairobi, Kenya, and are targeting pharma and health programmes across Sub-Saharan Africa and emerging markets globally. The platform is designed for low-connectivity, high-dispersion environments — it works wherever patients have a smartphone and a data connection.

Yes. The platform suits any organisation running distributed patient or community health programmes that require verified behavioral data — NGOs, public health ministries, development funders, and foundations included. Contact us to discuss programme-specific pricing.

A scoped feasibility assessment — no commitment required. We map your existing pharmacy or distributor network against the Play4Health verification model and deliver a concrete picture of what verified adherence data and device return volumes you could generate, how fast, and at what cost. Delivered within one week. Request yours →

A standard pilot onboarding takes 4–6 weeks: programme configuration, verification logic setup, dashboard configuration, and a supervised pilot run. A one-time setup fee applies per programme (from USD 5–15K for pilots; USD 10–30K for national rollouts depending on scope).

Annual licensing starts from €50,000 (Care Proof Starter) for a single brand and country, up to €250,000+ for multi-market enterprise programmes. All tiers include the full behavioral platform — verified adherence, device returns, gamification, and dashboard. You pay for what gets verified. See full pricing → or contact us for a custom quote.

Many markets are introducing EPR obligations for pharmaceutical packaging, including inhalers and single-use injection devices. Play4Health generates photo-verified device return records with timestamps and geo-tags — audit-ready evidence for EPR reporting. This data is also exportable for CSRD and Scope 3 submissions.

Yes. Device return volumes and packaging recovery data generated through Play4Health can be structured to support CSRD disclosure and Scope 3 Category 12 (end-of-life treatment of sold products) reporting. We recommend using this data as field-level evidence alongside your broader ESG reporting framework.

Each client programme runs in an isolated multi-tenant environment. Patient data (photos, timestamps, engagement records) is stored securely and accessible only to that programme's authorised administrators. Data is never shared between client programmes. Deploying organisations are responsible for ensuring compliance with applicable patient data protection laws in their operating markets.

Terms of Use  ·  Privacy Policy